Somany Ceramics Limited has informed the Exchange about Transcript
SOMANYCERA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Somany Ceramics reported Q4 FY25 sales growth of 5% with volume up 3%, but EBITDA margin for the full year contracted to 8.4% (from 9.8%) due to a 2.8% gross margin decline and capacity utilization falling to 81% (from 86%). The Bathware segment was a bright spot, growing 18% in Q4 and 11% for FY25, while the loss-making Max plant (55% utilization) remains the key drag. Management guided for high single-digit to low double-digit revenue growth and a 1–1.5% EBITDA margin improvement in FY26, with the Max plant expected to reach 75% capacity utilization by H2 FY26. Total debt stood at INR288 crores (up from INR233 crores), and management expects industry consolidation with 70–80 Morbi plants likely to shut this year.
Forward-looking guidance on margin recovery and revenue growth is positive, but near-term margin pressure, elevated debt, and the Max plant turnaround risk remain overhangs for the stock.